REG - Commercial Int Bank - 3rd Quarter Results
04/11/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251104:nRSD0095Ga&default-theme=true
RNS Number : 0095G Commercial Intnl Bank (Egypt) SAE 03 November 2025
Condensed Separate Interim Statement of Financial Position as at September 30,
2025
Notes Sep. 30, 2025 Dec. 31, 2024
Assets
Cash and balances at the central bank 10 20,916,631 136,165,920
Due from banks 11 228,152,325 270,089,441
Loans and advances to banks, net 13 26,914,884 9,555,410
Loans and advances to customers, net 14 452,110,898 340,955,698
Derivative financial instruments 1,222,908 819,711
Financial investments
- Financial Assets at Fair Value through P&L 15 2,203,869 -
- Financial Assets at Fair Value through OCI 15 329,796,707 233,029,903
- Financial Assets at Amortized cost 15 228,915,634 167,276,956
Investments in subsidiaries and associates 16 1,255,421 871,525
Non-current assets held for sale 30 159,828 159,828
Other assets 17 49,915,056 44,175,232
Deferred tax assets 2,457,493 2,337,304
Property and equipment 18 5,470,642 3,881,620
Total assets 1,349,492,296 1,209,318,548
Liabilities and equity
Liabilities
Due to banks 19 7,043,881 2,317,715
Due to customers 20 1,043,204,762 967,895,387
Derivative financial instruments 223,670 100,571
Current income tax liabilities 15,857,818 18,327,968
Other liabilities 21 26,802,780 21,347,499
Issued debt instruments 22 4,779,461 5,067,781
Other loans 30,249,278 23,962,389
Other provisions 23 14,478,190 18,613,060
Total liabilities 1,142,639,840 1,057,632,370
Equity
Issued and paid capital 30,708,510 30,431,580
Reserves 105,209,974 63,125,912
Reserve for employee stock ownership plan (ESOP) 2,071,247 1,868,235
Retained earnings* 68,862,725 56,260,451
Total equity and net profit for the period / year 206,852,456 151,686,178
Total liabilities and equity 1,349,492,296 1,209,318,548
The accompanying notes are an integral part of these financial statements.
(Review report attached)
* Including net profit for the period
Condensed Separate Interim Statement of Financial Position as at September 30,
2025
Notes
Sep. 30, 2025
Dec. 31, 2024
Assets
Cash and balances at the central bank
10
20,916,631
136,165,920
Due from banks
11
228,152,325
270,089,441
Loans and advances to banks, net
13
26,914,884
9,555,410
Loans and advances to customers, net
14
452,110,898
340,955,698
Derivative financial instruments
1,222,908
819,711
Financial investments
- Financial Assets at Fair Value through P&L
15
2,203,869
-
- Financial Assets at Fair Value through OCI
15
329,796,707
233,029,903
- Financial Assets at Amortized cost
15
228,915,634
167,276,956
Investments in subsidiaries and associates
16
1,255,421
871,525
Non-current assets held for sale
30
159,828
159,828
Other assets
17
49,915,056
44,175,232
Deferred tax assets
2,457,493
2,337,304
Property and equipment
18
5,470,642
3,881,620
Total assets
1,349,492,296
1,209,318,548
Liabilities and equity
Liabilities
Due to banks
19
7,043,881
2,317,715
Due to customers
20
1,043,204,762
967,895,387
Derivative financial instruments
223,670
100,571
Current income tax liabilities
15,857,818
18,327,968
Other liabilities
21
26,802,780
21,347,499
Issued debt instruments
22
4,779,461
5,067,781
Other loans
30,249,278
23,962,389
Other provisions
23
14,478,190
18,613,060
Total liabilities
1,142,639,840
1,057,632,370
Equity
Issued and paid capital
30,708,510
30,431,580
Reserves
105,209,974
63,125,912
Reserve for employee stock ownership plan (ESOP)
2,071,247
1,868,235
Retained earnings*
68,862,725
56,260,451
Total equity and net profit for the period / year
206,852,456
151,686,178
Total liabilities and equity
1,349,492,296
1,209,318,548
The accompanying notes are an integral part of these financial statements.
(Review report attached)
*
Including net profit for the period
Condensed Separate Interim Income Statement for the period ended September 30,
2025
Last 9 Months Last 9 Months
Notes Sep. 30, 2025 Sep. 30, 2024
Interest and similar income 157,761,416 130,537,149
Interest and similar expense (79,403,286) (65,010,779)
Net interest income 78,358,130 65,526,370
Fee and commission income 11,565,784 9,257,495
Fee and commission expense (5,224,939) (4,048,928)
Net fee and commission income 6,340,845 5,208,567
Dividend income 125,185 100,858
Net trading income 6 1,276,502 18,177,630
Profits (Losses) on financial investments 15.1 598,228 377,992
Administrative expenses (11,880,346) (8,795,429)
Other operating income (expenses) 7 687,384 (17,980,232)
Impairment release (charges) for credit losses 9 7,976,997 (3,741,208)
Profit before income tax 83,482,925 58,874,548
Income tax expense 27 (21,867,730) (16,964,163)
Deferred tax assets (Liabilities) 27 592,311 646,991
Net profit for the period 62,207,506 42,557,376
Earnings per share 8
Basic 18.54 12.50
Diluted 18.36 12.38
Condensed Separate Interim Statement of Comprehensive Income for the period
ended September 30, 2025
Last 9 Months Last 9 Months
Sep. 30, 2025 Sep. 30, 2024
Net profit for the period 62,207,506 42,557,376
Transferred to RE from financial assets at fair value through OCI 3,586 (370,224)
Net change on financial assets at fair value through comprehensive income 6,805,836 8,284,110
after tax
Effect of ECL on fair value of debt instruments measured at fair value through (399,884) 624,524
comprehensive income
Total comprehensive income for the period 68,617,044 51,095,786
Condensed Separate Interim Cash Flows for the period ended September 30, 2025
Notes Sep. 30, 2025 Sep. 30, 2024
Cash flow from operating activities
Profit before income tax 83,482,925 58,874,548
Adjustments to reconcile profits to net cash provided by operating
activities
Fixed assets depreciation 18 1,244,370 763,079
Impairment release/charge for credit losses (Loans and advances to customers 9 (7,980,073) 4,226,051
and banks)
Net charged/released for other provisions 23 (4,080,370) 429,182
Impairment release/charge for credit losses (due from banks) 9 151,236 (5)
Impairment release/charge for credit losses (financial investments) 9 (148,160) (484,838)
Impairment release/charge for other assets - (11,956)
Exchange revaluation differences for financial assets at fair value through 4,669,694 (18,536,183)
OCI and AC
Revaluation differences impairment charge for Financial Assets at Fair value (225,004) 1,199,896
through OCI
Revaluation differences impairment charge for Financial Assets at Amortized (16,709) 107,207
cost
Revaluation differences impairment charge for due from banks (7,813) 107
Net utilized/recovered for other provisions 23 (2,039) (9,196)
Exchange revaluation differences of other provisions 23 (52,461) 3,963,023
Profits/losses from selling property and equipment (8,006) (2,254)
Profits/losses from selling financial investments at fair value through OCI 15.1 (416,668) (377,992)
Profits/losses from selling investments in associates 15.1 (181,560) -
Share based payments 990,324 804,345
Operating profits before changes in operating assets and liabilities 77,419,686 50,945,014
Net decrease / increase in assets and liabilities
Due from banks 158,353,929 (24,748,544)
Financial assets at fair value through P&L (2,203,869) (2,066,889)
Derivative financial instruments (306,569) (229,127)
Loans and advances to banks and customers (120,567,170) (74,803,105)
Other assets (2,706,703) (14,036,648)
Due to banks 19 4,726,166 (8,606,431)
Due to customers 20 75,309,375 221,382,197
Current income tax obligations paid (6,009,912) (2,694,657)
Other liabilities (12,872,687) (6,305,033)
Net cash generated from (used in) operating activities 171,142,246 138,836,777
Cash flow from investing activities
Proceeds from sale of investments in associates 339,920 11,956
Payments for investment in subsidiaries (542,256) (200,000)
Payments for purchases of property, equipment and branches construction (5,833,944) (2,284,236)
Proceeds from selling property and equipment 7 8,006 2,254
Proceeds from redemption of financial assets at amortized cost 21,249,023 1,093,724
Payments for purchases of financial assets at amortized cost (83,115,289) (105,723,312)
Payments for purchases of financial assets at fair value through OCI (192,334,673) (21,646,713)
Proceeds from selling financial assets at fair value through OCI 98,063,752 67,015,091
Net cash generated from (used in) investing activities (162,165,461) (61,731,236)
Condensed Separate Interim Cash Flows for the period ended September 30, 2025
(Cont.)
Sep. 30, 2025 Sep. 30, 2024
Cash flow from financing activities
Other loans 6,286,889 7,840,786
Dividends (14,714,434) (5,078,792)
Issued debt instruments (288,320) 1,738,393
Capital increase 276,930 236,570
Net cash generated from (used in) financing activities (8,438,935) 4,736,957
Net (decrease) increase in cash and cash equivalent during the period 537,850 81,842,498
Beginning balance of cash and cash equivalent 227,028,744 233,912,193
Cash and cash equivalent at the end of the period 227,566,594 315,754,691
Cash and cash equivalent comprise:
Cash and balances at the central bank 10 20,916,631 94,285,689
Due from banks 228,295,965 304,041,410
Treasury bills and other governmental notes 12 140,546,840 82,174,775
Obligatory reserve balance with CBE (2,725,245) (76,128,521)
Due from banks with maturity more than three months (19,202,757) (17,846,556)
Treasury bills and other governmental notes with maturity more than three (140,264,840) (70,772,106)
months
Total cash and cash equivalent 227,566,594 315,754,691
Condensed Separate Interim statement of changes in shareholders' equity
Issued and paid capital Legal reserve General reserve General risk reserve Special reserve Capital reserve Reserve for financial assets at fair value through OCI Banking risks reserve Retained earnings Reserve for employee stock ownership plan Total
Sep. 30, 2024
Beginning Balance at 1 January 2024 30,195,010 4,770,354 39,840,707 1,549,445 - 21,155 (16,808,265) 15,230 29,230,360 1,486,010 90,300,006
Capital increase 236,570 - - - - - - - - - 236,570
Transferred to reserves - 1,438,320 22,582,085 - - 1,663 - - (23,398,943) (623,125) -
Dividend paid - - - - - - - - (5,366,429) - (5,366,429)
Net profit for the period - - - - - - - - 42,557,376 - 42,557,376
Transferred to RE from financial assets at fair value through OCI - - - - - - (370,224) - 370,224 - -
Net change on financial assets at fair value through OCI after tax - - - - - - 8,284,110 - - - 8,284,110
Transferred (from) to banking risk reserve - - - - - - - 2,694 (2,694) - -
Effect of ECL on debt instruments measured at fair value through OCI - - - - - - 624,524 - - - 624,524
Cost of employees stock ownership plan (ESOP) - - - - - - - - - 804,345 804,345
Balance at 30 September 2024 30,431,580 6,208,674 62,422,792 1,549,445 - 22,818 (8,269,855) 17,924 43,389,894 1,667,230 137,440,502
Issued and paid capital Legal reserve General reserve General risk reserve Special reserve Capital reserve Reserve for financial assets at fair value through OCI Banking risks reserve Retained earnings Reserve for employee stock ownership plan Total
Sep. 30, 2025
Beginning Balance at 1 January 2025 30,431,580 6,208,674 62,422,792 1,549,445 - 22,818 (7,095,741) 17,924 56,260,451 1,868,235 151,686,178
Capital increase 276,930 - - - - - - - - - 276,930
Transferred to reserves - 2,771,284 19,758,610 - - 2,246 - - (21,744,828) (787,312) -
Dividends paid - - - - - - - - (14,714,434) - (14,714,434)
Net profit for the period - - - - - - - - 62,207,506 - 62,207,506
Transferred to RE from financial assets at fair value through OCI - - - - - - 3,586 - (3,586) - -
Transferred from net profit to special reserve - - - - 13,145,012 - - - (13,145,012) - -
Net change on financial assets at fair value through OCI after tax - - - - - - 6,805,836 - - - 6,805,836
Transferred (from) to banking risk reserve - - - - - - - (2,628) 2,628 - -
Effect of ECL on debt instruments measured at fair value through OCI - - - - - - (399,884) - - - (399,884)
Cost of employees stock ownership plan (ESOP) - - - - - - - - - 990,324 990,324
Balance at 30 September 2025 30,708,510 8,979,958 82,181,402 1,549,445 13,145,012 25,064 (686,203) 15,296 68,862,725 2,071,247 206,852,456
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END QRTUPGGWGUPAGBW
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Commercial International Bank Egypt CIB
See all newsREG - Commercial Int Bank - 3rd Quarter Results
AnnouncementREG - Commercial Int Bank - CIB 9M25 Earnings Release
AnnouncementREG - Commercial Int Bank - CIB Condensed Consolidated 3rd Quarter Results
AnnouncementREG - Commercial Int Bank - Summary of Resolutions - GAM September 2025
AnnouncementREG - Commercial Int Bank - Invitation to General Assembly September 2025
Announcement